Lars Linzander

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Issuers on file
1
issuers named in insider transaction reports filed to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Oct 3, 2017 – Jul 9, 2020

Lars Linzander reported 11 transactions between Oct 3, 2017 and Jul 9, 2020. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
558.9K SEK
5 purchases on file priced rows only
Open-market sales (SDIS)
464.2K SEK
5 sales on file priced rows only
All reported transactions
11
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 11 most recent rows are grouped into 6 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. QuiaPEG Pharmaceuticals Holding AB SSUB Subscriptionnot a buy/sell decision 77,505 shares 542.5K SEK at 7.00 SEK FI filing ↗
  2. QuiaPEG Pharmaceuticals Holding AB SACQ Acquisition 35,000 shares 101.2K SEK at 2.89 SEK FI filing ↗
  3. QuiaPEG Pharmaceuticals Holding AB SACQ Acquisition × 3 267,136 shares 67.1K SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    10,000 2.21 SEK 22.1K SEK FI filing ↗
    1,865 2.62 SEK 4.9K SEK FI filing ↗
    255,271 0.16 SEK 40.1K SEK FI filing ↗
  4. QuiaPEG Pharmaceuticals Holding AB SDIS Disposal × 4 267,131 shares 73.5K SEK
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    10,000 2.17 SEK 21.7K SEK FI filing ↗
    1,865 2.46 SEK 4.6K SEK FI filing ↗
    97,366 0.23 SEK 22.6K SEK FI filing ↗
    157,900 0.16 SEK 24.6K SEK FI filing ↗
  5. QuiaPEG Pharmaceuticals Holding AB SACQ Acquisition 156,270 shares 390.7K SEK at 2.50 SEK FI filing ↗
  6. QuiaPEG Pharmaceuticals Holding AB SDIS Disposal 156,270 shares 390.7K SEK at 2.50 SEK FI filing ↗

Reconstructed positions

We hold no share-level ownership disclosure naming Lars Linzander. Anything this person is known to own appears in the stated-assets section above, quoted and attributed — we do not estimate what is missing.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.